Clinical Trial Update: Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Ingenol Mebutate (Picato) with methyl aminolevulinate photodynamic therapy for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Picato (ingenol mebutate)

Snippet

Sponsor: Pacific Dermaesthetics | Conditions: Actinic Keratosis | Phase 2 | Status: UNKNOWN